SHPH NASDAQ
Shuttle Pharmaceuticals Holdings, Inc.
1W: +6.1%
1M: +26.8%
3M: +87.4%
YTD: +187.8%
1Y: +67.0%
3Y: -94.7%
$5.21
+0.17 (+3.27%)
Weekly Expected Move ±16.0%
$3
$4
$5
$6
$7
Credit Risk of going bust: higher than 94% of companies Debt: 0.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.7%), Shuttle Pharmaceuticals Holdings, Inc. would be worth roughly what it owes.
Total debt $195K against a stock market value of $24.8M.
Distance to default 0.85 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $98K (short-term plus half of long-term), stock volatility 260.6%; Altman Z -0.82. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.02 (down 99.7%), Shuttle Pharmaceuticals Holdings, Inc. would be worth roughly what it owes.
Total debt $195K against a stock market value of $24.8M.
Distance to default 0.85 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $98K (short-term plus half of long-term), stock volatility 260.6%; Altman Z -0.82. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.2M
Congress—
ETF Holdings—
Key Statistics
Market Cap$24.8M
52W Range2.576-44.4
Volume10,350
Avg Volume1,527,736
Beta1.14
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChristopher Robert Cooper
Employees2
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2022-08-31
Websiteshuttlepharma.com
401 Professional Drive
Gaithersburg, MD 20879
US
Gaithersburg, MD 20879
US
240 403 4212
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Latest News
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Short Interest Update
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| HRT FINANCIAL LP | S-Sale | 82,116 | $4.48 | 2026-07-14 |
| HRT FINANCIAL LP | S-Sale | 1,033 | $4.67 | 2026-07-13 |
| HRT FINANCIAL LP | P-Purchase | 731 | $3.11 | 2026-07-10 |
| HRT FINANCIAL LP | 0 | — | 2026-07-09 | |
| HRT FINANCIAL LP | P-Purchase | 8,266 | $3.38 | 2026-07-09 |